MTA2 and adrenal cortex carcinoma: We concluded that the expression of MTA2 was significantly associated with the DFS, DSS, and PFS of ACC (DFS: p < 0.001; DSS: p = 0.029; PFS: p = 0.004), CHOL (DFS: p = 0.016), ESCA (DFS: p = 0.021; DSS: p = 0.019), OV (DFS: p = 0.002; PFS: p = 0.004), PRAD (DFS: p = 0.043; PFS: p = 0.011), KIRC (DSS: p = 0.043), STAD (PFS: p < 0.001), UCEC (DSS: p = 0.01), ESCA (DFS: p = 0.021; DSS: p = 0.019; PFS: p = 0.031), GBM (PFS: p = 0.019) and UVM (PFS: p = 0.033) (Figure 5).